Patent details
LUC00186 Product Name: alpelisib ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- LUC00186
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP097827778
- Legal Status:
- Inactive
- Application number:
- LUC00186
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/20/1455
- Marketing Authorization Type:
- Marketing Authorization Date:
- 28/07/2020
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- 67359
- Marketing Authorization Type:
- Marketing Authorization Date:
- 24/03/2020
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Switzerland (CH)
Dates
- Filing date:
- 20/11/2020
- First Marketing Authorization date:
- 24/03/2020
- Grant date:
- 01/07/2024
- Activation date:
- Publication date:
- 20/11/2020
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 08/09/2034
- SPC Extension Expiration:
- 08/09/2034
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/11/2020
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 20/11/2020
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2020/13
- Publication date:
- 07/12/2020
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/10
- Publication date:
- 06/08/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 01/10/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 12/11/2021 | Marketing authorization | 44 |
| 20/11/2020 | Application Form | 4 |
| 15/11/2021 | Outgoing Correspondence | 1 |
| 20/11/2020 | Marketing authorization | 3 |
| 12/11/2021 | General Document | 1 |
| 12/11/2021 | Incoming Correspondence (Post) | 2 |
| 20/11/2020 | Summary of the product caracteristics | 65 |
| 20/11/2020 | Outgoing Correspondence | 1 |
| 20/11/2020 | MA publication | 10 |
| 20/11/2020 | Publication | 1 |
| 01/07/2024 | Publication | 1 |
| 01/07/2024 | Certificate | 1 |
| 08/07/2024 | Outgoing Correspondence | 1 |